Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

All Positives May Not Be the Same in Pancreatic Cancer Lessons Learned From the Past

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.43, no.9, pp.676, 2020 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Cancer incidence in Behcet's Disease.

JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (Peer-Reviewed Journal) identifier

Classifying sarcopenia: using median value or cut-off values?

BREAST CANCER RESEARCH AND TREATMENT, vol.176, no.2, pp.479, 2019 (Peer-Reviewed Journal) identifier identifier identifier

Evaluation of cancer risk in patients with periodontal diseases

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.3, pp.826-831, 2019 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Noninferiority for Short-HER or short-chemotherapy?

ANNALS OF ONCOLOGY, vol.30, no.1, pp.147, 2019 (Peer-Reviewed Journal) identifier identifier identifier

Glucocorticoids in breast cancer treatment: real benefit or selection bias?

BREAST CANCER RESEARCH AND TREATMENT, vol.172, no.1, pp.243, 2018 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

CURRENT PROBLEMS IN CANCER, vol.42, no.3, pp.344-349, 2018 (Peer-Reviewed Journal) identifier identifier identifier

Fusobacterium and colorectal carcinogenesis

CARCINOGENESIS, vol.39, no.1, pp.84, 2018 (Peer-Reviewed Journal) identifier identifier identifier

Increased cancer risk in patients with periodontitis

CURRENT MEDICAL RESEARCH AND OPINION, vol.33, no.12, pp.2195-2200, 2017 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Interpretation of survival data: which graphical analysis is appropriate?

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol.8, no.4, pp.312, 2016 (Peer-Reviewed Journal) identifier identifier identifier

Analysis of the Adjuvant Hormone Therapy Randomized Trial

JOURNAL OF CLINICAL ONCOLOGY, vol.34, no.17, pp.2070-2071, 2016 (Peer-Reviewed Journal) identifier identifier identifier

Vaccination Attitudes Among Patients with Cancer Receiving Chemotherapy

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.3, pp.167-172, 2016 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Advances in PARP inhibitors for the treatment of breast cancer

EXPERT OPINION ON PHARMACOTHERAPY, vol.16, no.18, pp.2751-2758, 2015 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Tertiary Cancer Center Experience: Pregnancy-Associated Breast Cancer

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.4, pp.284-285, 2014 (Peer-Reviewed Journal) identifier identifier

Good Outcomes of Patients with Stage IB Endometrial Cancer with Surgery Alone

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.15, no.9, pp.3891-3893, 2014 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Nilotinib is Effective in Imatinib and Sunitinib Resistant GIST: A Case Report

HEPATO-GASTROENTEROLOGY, vol.58, no.107, pp.859-860, 2011 (Peer-Reviewed Journal) identifier identifier identifier

Ipsilateral Breast Cancer in a Patient with Poland's Syndrome

AMERICAN SURGEON, vol.77, no.2, pp.234-235, 2011 (Peer-Reviewed Journal) Sustainable Development identifier

Blood ABO groups and risk of breast cancer

MEDICAL ONCOLOGY, vol.27, no.4, pp.1433, 2010 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Systemic treatment in breast-cancer patients with brain metastasis

EXPERT OPINION ON PHARMACOTHERAPY, vol.11, no.7, pp.1089-1100, 2010 (Peer-Reviewed Journal) identifier identifier identifier

Skin metastasis of ovarian cancer: a rare entity

JOURNAL OF BUON, vol.15, no.2, pp.398-399, 2010 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Chemotherapy in Older Women with Breast Cancer

NEW ENGLAND JOURNAL OF MEDICINE, vol.361, no.10, pp.1023, 2009 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Pharmacotherapy of triple-negative breast cancer

EXPERT OPINION ON PHARMACOTHERAPY, vol.10, no.13, pp.2081-2093, 2009 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Emerging drugs in metastatic breast cancer

EXPERT OPINION ON EMERGING DRUGS, vol.14, no.1, pp.85-98, 2009 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Weekly paclitaxel in the adjuvant treatment of breast cancer

NEW ENGLAND JOURNAL OF MEDICINE, vol.359, no.3, pp.310, 2008 (Peer-Reviewed Journal) Sustainable Development identifier

Prognostic impact of bone turnover markers in multiple myeloma

JOURNAL OF CLINICAL ONCOLOGY, vol.26, no.15, 2008 (Peer-Reviewed Journal) identifier

Prognostic factors in breast cancer patients with brain metastases

JOURNAL OF NEURO-ONCOLOGY, vol.87, no.2, pp.193, 2008 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

BREAST CANCER RESEARCH AND TREATMENT, vol.107, no.2, pp.303, 2008 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.69, no.5, pp.1651, 2007 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Vitamin D intake and breast cancer risk in postmenopausal women

ARCHIVES OF INTERNAL MEDICINE, vol.167, no.22, pp.2532, 2007 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Rituximab-induced viral infections in lymphoma patients

JOURNAL OF CLINICAL ONCOLOGY, vol.25, no.18, 2007 (Peer-Reviewed Journal) identifier

Rituximab-related viral infections in lymphoma patients

LEUKEMIA & LYMPHOMA, vol.48, no.7, pp.1307-1312, 2007 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Orbital metastasis from adenocarcinoma of the colon

SOUTHERN MEDICAL JOURNAL, vol.98, no.8, pp.846-847, 2005 (Peer-Reviewed Journal) identifier identifier identifier

Obesity: an endocrine tumor?

MEDICAL HYPOTHESES, vol.63, no.5, pp.790-792, 2004 (Peer-Reviewed Journal) Sustainable Development identifier identifier identifier

Articles Published in Other Journals

Current and emerging treatment options in triple-negative breast cancer

ONCOLOGY REVIEWS, vol.4, no.1, pp.5-13, 2010 (Peer-Reviewed Journal) Sustainable Development identifier identifier

Refereed Congress / Symposium Publications in Proceedings

Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30 identifier

Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30 Sustainable Development identifier

Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37 Sustainable Development identifier

Clinical features and prognosis of patients with liposarcoma: Single-center experience.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37 identifier

Kolorektal Kanserde 16S rDNA Sekanslama ile Oral Mikrobiyom Analizi

2. Ulusal immünoterapi ve Onkoloji Kongresi, Antalya, Turkey, 31 October - 04 November 2018 Sustainable Development

Evaluation of cancer risk in patients with periodontal diseases.

2018 ASCO Annual Meeting, Chicago, United States Of America, 1 - 05 June 2018, vol.36, pp.13571 Sustainable Development identifier

Correlation of histopahologic response and prognostic markers with survival in locally advanced non-small cell lung cancer patients who have treated with neoadjuvant chemotherapy.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 Sustainable Development identifier

Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 Sustainable Development identifier

Signet ring cell carcinoma of breast: Single center experience.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development identifier

Is there any correlation between molecular subtypes and blood groups in breast cancer?

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development identifier

Impact of comorbidities on recurrence rates and survival in patients with endometrial cancer.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development identifier

Outcomes of patients with endometrial cancer and aggressive histology.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development identifier

Impact of treatment strategies on local control and survival in uterine carcinosarcomas.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 identifier

Retrospective analysis of stage IIIc uterine carcinoma patients: A single center experience.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 identifier

Retrospective analysis of octagenarian breast cancer patients: Multicenter retrospective study.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 Sustainable Development identifier

Outcome of breast cancer patients with stage I diesease: A retrospective analysis

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 Sustainable Development identifier

Retrospective analysis of stage IC uterine cancer patients: A single center experience.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 Sustainable Development identifier

The Frequency and Determinants of Metabolic Syndrome in Patients with Operable Stage I-III Breast Cancer.

32nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 9 - 13 December 2009, vol.69 Sustainable Development identifier

Zoledronic acid and atrial fibrillation in cancer patients with bone metastases

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27 Sustainable Development identifier

Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27 Sustainable Development identifier

Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 identifier

What does determine homocysteine levels in hemodialysis patients: Nutrition or inflammation?

36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO, CALIFORNIA, 12 - 17 November 2003, vol.14 identifier

Books & Book Chapters

Nutrition and Cachexia in Gastrointestinal Cancer Patients

in: Textbook of Gastrointestinal Oncology, Yalçın Şuayib, Philip A. Philip, Editor, Springer, pp.379-394, 2019

esophaeal and gastroesophaeal junction tumors

in: textbook of gastrointestinal oncology, Suayib Yalcin, Philip a. Philip, Editor, springer, pp.55-72, 2019